A WHO-supported STEPS survey has identified low levels of physical activity and inadequate consumption of fruits and ...

Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to ...

Obesity is a growing global health crisis, affecting millions of people and increasing the risk of chronic diseases like diabetes, heart disease, and stroke. However, the good news is that obesity is ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study published in the journal Cell Reports has discovered that people living ...

SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep dives into clinical, social, and ...

Obesity is linked to numerous health complications, including diabetes, cardiovascular disease, and fatty liver disease. In a world where obesity rates continue to climb, researchers are constantly ...

The Alberta health agency for primary and preventative care is now partnering with Obesity Canada in order to tackle what ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

Emerging evidence links prenatal biology and early-life exposures to later obesity risk, suggesting that prevention may need ...